Herriot Tabuteau

2020

In 2020, Herriot Tabuteau earned a total compensation of $7.3M as Chief Executive Officer, President and Chairman of the Board at Axsome Therapeutics, a 55% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$448,500
Option Awards$4,665,329
Salary$575,000
Stock Awards$1,615,860
Total$7,304,690

Tabuteau received $4.7M in option awards, accounting for 64% of the total pay in 2020.

Tabuteau also received $448.5K in non-equity incentive plan, $575K in salary and $1.6M in stock awards.

Rankings

In 2020, Herriot Tabuteau's compensation ranked 1,312th out of 13,090 executives tracked by ExecPay. In other words, Tabuteau earned more than 90.0% of executives.

ClassificationRankingPercentile
All
1,312
out of 13,090
90th
Division
Manufacturing
471
out of 5,617
92nd
Major group
Chemicals And Allied Products
165
out of 2,248
93rd
Industry group
Drugs
142
out of 1,948
93rd
Industry
Pharmaceutical Preparations
103
out of 1,453
93rd

Pay ratio

Herriot Tabuteau's Pay$7,304,690
Median Employee's Pay$299,771
Pay Ratio

24

to 1

In 2020, the annual total compensation of Herriot Tabuteau was $7,304,690.

The annual total compensation of the median employee at Axsome Therapeutics was $299,771.

The ratio of Herriot Tabuteau's pay to the pay of median employee was therefore 24 to one.

Source: SEC filing on April 23, 2021.

Tabuteau's colleagues

We found three more compensation records of executives who worked with Herriot Tabuteau at Axsome Therapeutics in 2020.

2020

David Marek

Axsome Therapeutics

Former Chief Commercial Officer

2020

Nick Pizzie

Axsome Therapeutics

Chief Financial Officer

2020

Mark MA

Axsome Therapeutics

Chief Operating Officer

News

In-depth

You may also like